Company / Profit Margin
Kiniksa Pharmaceuticals International, plc Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
8.7%
FY2025
5-year range
-419.9% / 83.3%
FY2021-FY2025
Trend
+185.3%
vs FY2024
Sector context
#41 of 145
Health Care
What the data says
At 8.7%, Kiniksa Pharmaceuticals International, plc's profit margin ranks #41 of 145 in the Health Care sector. Profit Margin returned to growth in FY2025 after 2 years of decline, reaching 8.7%.
Based on SEC 10-K filings.
8.7% in FY2025 with a 3-year CAGR of -74.6%.
Improved from 5.2% to 8.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -74.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#41 of 145 in Health CareTop 28% of 145This company 8.7% Sector average -792.7%
▼
+101.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 185.3% year-over-year.
- Currently 801.4pp above the Health Care sector average.
- Peak profit margin was recorded in FY2022.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.7% | +185.3% |
| FY2024 | -10.2% | -296.0% |
| FY2023 | 5.2% | -93.7% |
| FY2022 | 83.3% | +119.8% |
| FY2021 | -419.9% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026